Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2019 Filed Nov 13, 2019 21:08 UTC |
Kewalramani ReshmaEVP and CMO
|
Exercise / conversionCommon Stock | 509 | $155.57 | $79,185.13 |
DisclosureSEC source: 0001209191-19-056327 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,223 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-19-055674 · doc4.xml · derivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,006 Underlying: Common Stock · 1,223 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 210 | $197.90 | $41,559.00 |
DisclosureSEC source: 0001209191-19-055674 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,553 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $197.90 (range $197.83 to $198.00). Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 770 | $197.38 | $151,982.60 |
DisclosureSEC source: 0001209191-19-055674 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,763 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $197.38 (range $196.81 to $197.80). Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 243 | $196.08 | $47,647.44 |
DisclosureSEC source: 0001209191-19-055674 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,533 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $196.08 (range $195.80 to $196.41). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 21:36 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,223 | $155.57 | $190,262.11 |
DisclosureSEC source: 0001209191-19-055674 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,330 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · derivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,650 Underlying: Common Stock · 2,330 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,796 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · derivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,796 Underlying: Common Stock · 1,796 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 800 | $201.23 | $160,984.00 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,553 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $201.23 (range $200.88 to $201.33). Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 3,326 | $200.26 | $666,064.76 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,353 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $200.26 (range $199.83 to $200.81). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 2,330 | $86.52 | $201,591.60 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:10 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,796 | $91.05 | $163,525.80 |
DisclosureSEC source: 0001209191-19-055467 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,553 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · derivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,767 Underlying: Common Stock · 1,553 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,155 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · derivative · entry 6 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156 Underlying: Common Stock · 2,155 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 1,553 | $201.62 | $313,115.86 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,553 | $86.52 | $134,365.56 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 2,155 | $201.62 | $434,491.10 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,240 Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:11 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,155 | $91.05 | $196,212.75 |
DisclosureSEC source: 0001209191-19-055468 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:13 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,330 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-055469 · doc4.xml · derivative · entry 4 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,650 Underlying: Common Stock · 2,330 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:13 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 600 | $201.37 | $120,822.00 |
DisclosureSEC source: 0001209191-19-055469 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,003 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $201.37 (range $201.33 to $201.39). Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:13 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 1,730 | $200.20 | $346,346.00 |
DisclosureSEC source: 0001209191-19-055469 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,603 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $200.20 (range $199.81 to $200.52). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:13 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 2,330 | $86.52 | $201,591.60 |
DisclosureSEC source: 0001209191-19-055469 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,942 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · derivative · entry 9 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,708 Underlying: Common Stock · 1,942 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,155 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · derivative · entry 8 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156 Underlying: Common Stock · 2,155 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/02/2016. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 1,100 | $201.10 | $221,210.00 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,416 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $201.10 (range $200.86 to $201.26). Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 2,497 | $200.12 | $499,699.64 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,516 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $200.12 (range $199.83 to $200.53). Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 500 | $199.77 | $99,885.00 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,013 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $199.77 (range $199.76 to $199.79). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionCommon Stock | 1,942 | $86.52 | $168,021.84 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:15 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionCommon Stock | 2,155 | $91.05 | $196,212.75 |
DisclosureSEC source: 0001209191-19-055470 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:11 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,291 | $0.00 Strike: $152.74 | $0.00 |
DisclosureSEC source: 0001209191-19-054871 · doc4.xml · derivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,938 Underlying: Common Stock · 1,291 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:11 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 1,291 | $200.00 | $258,200.00 |
DisclosureSEC source: 0001209191-19-054871 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,249 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:11 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionCommon Stock | 1,291 | $152.74 | $197,187.34 |
DisclosureSEC source: 0001209191-19-054871 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,532 | $0.00 Strike: $131.89 | $0.00 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · derivative · entry 10 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,678 Underlying: Common Stock · 26,532 shares Expires 2025-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 70,290 | $0.00 Strike: $109.14 | $0.00 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · derivative · entry 9 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,290 Underlying: Common Stock · 70,290 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 26,532 | $200.06 | $5,307,991.92 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,287 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $200.06 (range $200.00 to $200.10). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 26,532 | $131.89 | $3,499,305.48 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 70,290 | $200.00 | $14,058,000.00 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,287 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:13 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 70,290 | $109.14 | $7,671,450.60 |
DisclosureSEC source: 0001209191-19-054876 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,073 | $0.00 Strike: $93.51 | $0.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · derivative · entry 14 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,073 shares Expires 2026-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $72.14 | $0.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · derivative · entry 13 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 375 | $0.00 Strike: $56.99 | $0.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · derivative · entry 12 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 375 shares Expires 2021-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · derivative · entry 11 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
SaleCommon Stock | 7,073 | $200.00 | $1,414,600.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 10 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811 F1 · kind: Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionCommon Stock | 7,073 | $93.51 | $661,396.23 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 9 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
SaleCommon Stock | 20,000 | $200.00 | $4,000,000.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 8 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811 F1 · kind: Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionCommon Stock | 20,000 | $72.14 | $1,442,800.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 7 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
SaleCommon Stock | 375 | $200.00 | $75,000.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 6 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811 F1 · kind: Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionCommon Stock | 375 | $56.99 | $21,371.25 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 5 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
SaleCommon Stock | 20,000 | $200.00 | $4,000,000.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 4 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,811 F1 · kind: Transaction made pursuant to Mr. Kearney's company approved trading plan under Rule 10b5-1. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Kearney Terrence CDirector
|
Exercise / conversionCommon Stock | 20,000 | $81.54 | $1,630,800.00 |
DisclosureSEC source: 0001209191-19-054882 · doc4.xml · nonDerivative · entry 3 Kearney Terrence C · CIK 0001289098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.